Christian Angermayer(II)
- Producer
Christian Angermayer is a serial entrepreneur, investor, and founder of his private investment firm, Apeiron Investment Group (www.apeiron-investments.com). Passionate about the arts and film, Christian has acted as executive producer on 26 feature films to date, including the critically acclaimed movies Filth (2013), Hector and the Search for Happiness (2014), Resistance (2020) and the upcoming Zack Snyder movie Army of Thieves.
With more than USD 3.5 billion under management and 50 FTEs across five international locations, his Apeiron Investment Group focuses on Life Sciences, FinTech/InsurTech/PropTech/Crypto, and FutureTech (e.g. SpaceTech, FoodTech, AI).
Apeiron has a global approach and deploys its capital across the entire company lifecycle, from founding companies inhouse, seed/startup investments to large-scale investments in listed companies. As Apeiron invests predominantly its own capital, the team is able to be highly entrepreneurial, reliable and flexible.
A key company within the Apeiron portfolio is atai Life Sciences (NASDAQ: ATAI), which was founded by Christian in 2018. atai is already making significant headway towards unlocking innovative treatments to improve the status quo for the one billion plus people worldwide suffering from mental health issues, including depression, anxiety, addiction, and post-traumatic stress disorder. atai currently has multiple projects underway to investigate the potential of psychedelic compounds like "magic mushrooms" / psilocybin, DMT (N-Dimethyltryptamine) and Ibogaine, and establish these as approved medical treatments.
With his biotech companies rejuveron Life Sciences and Cambrian Biopharma, Christian is developing medical drugs with the aim to significantly prolong the human life span. Because, after all, what we most desire is to live a healthier, happier and longer life.
Christian's Angermayer Policy and Innovation Forum convenes several times a year, comprising international Head of States, politicians, investors, and scientists, to discuss and address crucial global priorities.
UK Newspaper Sunday Times ranks Christian among the 200 richest people living in the United Kingdom with an estimated net worth of approx. USD 1.2 billion.
With more than USD 3.5 billion under management and 50 FTEs across five international locations, his Apeiron Investment Group focuses on Life Sciences, FinTech/InsurTech/PropTech/Crypto, and FutureTech (e.g. SpaceTech, FoodTech, AI).
Apeiron has a global approach and deploys its capital across the entire company lifecycle, from founding companies inhouse, seed/startup investments to large-scale investments in listed companies. As Apeiron invests predominantly its own capital, the team is able to be highly entrepreneurial, reliable and flexible.
A key company within the Apeiron portfolio is atai Life Sciences (NASDAQ: ATAI), which was founded by Christian in 2018. atai is already making significant headway towards unlocking innovative treatments to improve the status quo for the one billion plus people worldwide suffering from mental health issues, including depression, anxiety, addiction, and post-traumatic stress disorder. atai currently has multiple projects underway to investigate the potential of psychedelic compounds like "magic mushrooms" / psilocybin, DMT (N-Dimethyltryptamine) and Ibogaine, and establish these as approved medical treatments.
With his biotech companies rejuveron Life Sciences and Cambrian Biopharma, Christian is developing medical drugs with the aim to significantly prolong the human life span. Because, after all, what we most desire is to live a healthier, happier and longer life.
Christian's Angermayer Policy and Innovation Forum convenes several times a year, comprising international Head of States, politicians, investors, and scientists, to discuss and address crucial global priorities.
UK Newspaper Sunday Times ranks Christian among the 200 richest people living in the United Kingdom with an estimated net worth of approx. USD 1.2 billion.
